The effect of pelvic floor muscle training in women with functional bladder outlet obstruction
Introduction and hypothesis Female voiding dysfunction is often due to bladder outlet obstruction (BOO). We investigated pelvic floor muscle training (PFMT) effectiveness in women with functional BOO. Methods This is a prospective study recruiting 63 women functionally obstructed, over 18yo, maximum...
Saved in:
Published in | Archives of gynecology and obstetrics Vol. 307; no. 5; pp. 1489 - 1494 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.05.2023
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 1432-0711 0932-0067 1432-0711 |
DOI | 10.1007/s00404-023-06930-z |
Cover
Abstract | Introduction and hypothesis
Female voiding dysfunction is often due to bladder outlet obstruction (BOO). We investigated pelvic floor muscle training (PFMT) effectiveness in women with functional BOO.
Methods
This is a prospective study recruiting 63 women functionally obstructed, over 18yo, maximum flow rate (Qmax) less than 12 ml/sec, naïve of voiding treatment. Exclusion criteria were anatomical BOO, neurological condition, pelvic intervention, psychiatric or anticholinergic medication, diabetes mellitus and affected upper urinary tract. At baseline, women underwent uroflow, post void residual (PVR) measurement, cystoscopy, cystogram and urodynamic study (UDS) with pelvic electromyography (EMG). Blaivas-Groutz nomogram has been used to define obstruction. After diagnosis, patients underwent six-month PFMT. Re-evaluation was offered four weeks after end of treatment. Data were analyzed with SPSSv22.0.
Results
63 women were recruited and 48 finally included. At baseline, 20 reported 3 urinary tract infections (UTIs) during last year, and 12 had one episode of urine retention. Median Qmax was 7.5 ml/sec and median PVR 110 ml. 40 women were obstructed. 16 (40%) had mild, 16 (40%) moderate and 8 (20%) severe obstruction. All subjects had an overactive pelvic floor on EMG. Obstructed women were re-evaluated. Median Qmax was 8.5 ml/sec, close to baseline (
p
= 0.16). Median PVR was 65 ml, reduced to baseline (
p
= 0.02). 33 (82.5%) remained obstructed, 22 (66.67%) with mild, 8 (24.24%) moderate and 3 (9.09%) severe obstruction. 7 (17.5%) were non-obstructed. 4 patients reported one UTI episode with no cases of retention.
Conclusions
A 6 month PFMT reduced UTIs and PVR in women with functional BOO. Additionally, most patients had a de-escalation to milder obstruction. |
---|---|
AbstractList | Introduction and hypothesis
Female voiding dysfunction is often due to bladder outlet obstruction (BOO). We investigated pelvic floor muscle training (PFMT) effectiveness in women with functional BOO.
Methods
This is a prospective study recruiting 63 women functionally obstructed, over 18yo, maximum flow rate (Qmax) less than 12 ml/sec, naïve of voiding treatment. Exclusion criteria were anatomical BOO, neurological condition, pelvic intervention, psychiatric or anticholinergic medication, diabetes mellitus and affected upper urinary tract. At baseline, women underwent uroflow, post void residual (PVR) measurement, cystoscopy, cystogram and urodynamic study (UDS) with pelvic electromyography (EMG). Blaivas-Groutz nomogram has been used to define obstruction. After diagnosis, patients underwent six-month PFMT. Re-evaluation was offered four weeks after end of treatment. Data were analyzed with SPSSv22.0.
Results
63 women were recruited and 48 finally included. At baseline, 20 reported 3 urinary tract infections (UTIs) during last year, and 12 had one episode of urine retention. Median Qmax was 7.5 ml/sec and median PVR 110 ml. 40 women were obstructed. 16 (40%) had mild, 16 (40%) moderate and 8 (20%) severe obstruction. All subjects had an overactive pelvic floor on EMG. Obstructed women were re-evaluated. Median Qmax was 8.5 ml/sec, close to baseline (
p
= 0.16). Median PVR was 65 ml, reduced to baseline (
p
= 0.02). 33 (82.5%) remained obstructed, 22 (66.67%) with mild, 8 (24.24%) moderate and 3 (9.09%) severe obstruction. 7 (17.5%) were non-obstructed. 4 patients reported one UTI episode with no cases of retention.
Conclusions
A 6 month PFMT reduced UTIs and PVR in women with functional BOO. Additionally, most patients had a de-escalation to milder obstruction. Female voiding dysfunction is often due to bladder outlet obstruction (BOO). We investigated pelvic floor muscle training (PFMT) effectiveness in women with functional BOO. This is a prospective study recruiting 63 women functionally obstructed, over 18yo, maximum flow rate (Qmax) less than 12 ml/sec, naïve of voiding treatment. Exclusion criteria were anatomical BOO, neurological condition, pelvic intervention, psychiatric or anticholinergic medication, diabetes mellitus and affected upper urinary tract. At baseline, women underwent uroflow, post void residual (PVR) measurement, cystoscopy, cystogram and urodynamic study (UDS) with pelvic electromyography (EMG). Blaivas-Groutz nomogram has been used to define obstruction. After diagnosis, patients underwent six-month PFMT. Re-evaluation was offered four weeks after end of treatment. Data were analyzed with SPSSv22.0. 63 women were recruited and 48 finally included. At baseline, 20 reported 3 urinary tract infections (UTIs) during last year, and 12 had one episode of urine retention. Median Qmax was 7.5 ml/sec and median PVR 110 ml. 40 women were obstructed. 16 (40%) had mild, 16 (40%) moderate and 8 (20%) severe obstruction. All subjects had an overactive pelvic floor on EMG. Obstructed women were re-evaluated. Median Qmax was 8.5 ml/sec, close to baseline (p = 0.16). Median PVR was 65 ml, reduced to baseline (p = 0.02). 33 (82.5%) remained obstructed, 22 (66.67%) with mild, 8 (24.24%) moderate and 3 (9.09%) severe obstruction. 7 (17.5%) were non-obstructed. 4 patients reported one UTI episode with no cases of retention. A 6 month PFMT reduced UTIs and PVR in women with functional BOO. Additionally, most patients had a de-escalation to milder obstruction. Introduction and hypothesisFemale voiding dysfunction is often due to bladder outlet obstruction (BOO). We investigated pelvic floor muscle training (PFMT) effectiveness in women with functional BOO.MethodsThis is a prospective study recruiting 63 women functionally obstructed, over 18yo, maximum flow rate (Qmax) less than 12 ml/sec, naïve of voiding treatment. Exclusion criteria were anatomical BOO, neurological condition, pelvic intervention, psychiatric or anticholinergic medication, diabetes mellitus and affected upper urinary tract. At baseline, women underwent uroflow, post void residual (PVR) measurement, cystoscopy, cystogram and urodynamic study (UDS) with pelvic electromyography (EMG). Blaivas-Groutz nomogram has been used to define obstruction. After diagnosis, patients underwent six-month PFMT. Re-evaluation was offered four weeks after end of treatment. Data were analyzed with SPSSv22.0.Results63 women were recruited and 48 finally included. At baseline, 20 reported 3 urinary tract infections (UTIs) during last year, and 12 had one episode of urine retention. Median Qmax was 7.5 ml/sec and median PVR 110 ml. 40 women were obstructed. 16 (40%) had mild, 16 (40%) moderate and 8 (20%) severe obstruction. All subjects had an overactive pelvic floor on EMG. Obstructed women were re-evaluated. Median Qmax was 8.5 ml/sec, close to baseline (p = 0.16). Median PVR was 65 ml, reduced to baseline (p = 0.02). 33 (82.5%) remained obstructed, 22 (66.67%) with mild, 8 (24.24%) moderate and 3 (9.09%) severe obstruction. 7 (17.5%) were non-obstructed. 4 patients reported one UTI episode with no cases of retention.ConclusionsA 6 month PFMT reduced UTIs and PVR in women with functional BOO. Additionally, most patients had a de-escalation to milder obstruction. Female voiding dysfunction is often due to bladder outlet obstruction (BOO). We investigated pelvic floor muscle training (PFMT) effectiveness in women with functional BOO.INTRODUCTION AND HYPOTHESISFemale voiding dysfunction is often due to bladder outlet obstruction (BOO). We investigated pelvic floor muscle training (PFMT) effectiveness in women with functional BOO.This is a prospective study recruiting 63 women functionally obstructed, over 18yo, maximum flow rate (Qmax) less than 12 ml/sec, naïve of voiding treatment. Exclusion criteria were anatomical BOO, neurological condition, pelvic intervention, psychiatric or anticholinergic medication, diabetes mellitus and affected upper urinary tract. At baseline, women underwent uroflow, post void residual (PVR) measurement, cystoscopy, cystogram and urodynamic study (UDS) with pelvic electromyography (EMG). Blaivas-Groutz nomogram has been used to define obstruction. After diagnosis, patients underwent six-month PFMT. Re-evaluation was offered four weeks after end of treatment. Data were analyzed with SPSSv22.0.METHODSThis is a prospective study recruiting 63 women functionally obstructed, over 18yo, maximum flow rate (Qmax) less than 12 ml/sec, naïve of voiding treatment. Exclusion criteria were anatomical BOO, neurological condition, pelvic intervention, psychiatric or anticholinergic medication, diabetes mellitus and affected upper urinary tract. At baseline, women underwent uroflow, post void residual (PVR) measurement, cystoscopy, cystogram and urodynamic study (UDS) with pelvic electromyography (EMG). Blaivas-Groutz nomogram has been used to define obstruction. After diagnosis, patients underwent six-month PFMT. Re-evaluation was offered four weeks after end of treatment. Data were analyzed with SPSSv22.0.63 women were recruited and 48 finally included. At baseline, 20 reported 3 urinary tract infections (UTIs) during last year, and 12 had one episode of urine retention. Median Qmax was 7.5 ml/sec and median PVR 110 ml. 40 women were obstructed. 16 (40%) had mild, 16 (40%) moderate and 8 (20%) severe obstruction. All subjects had an overactive pelvic floor on EMG. Obstructed women were re-evaluated. Median Qmax was 8.5 ml/sec, close to baseline (p = 0.16). Median PVR was 65 ml, reduced to baseline (p = 0.02). 33 (82.5%) remained obstructed, 22 (66.67%) with mild, 8 (24.24%) moderate and 3 (9.09%) severe obstruction. 7 (17.5%) were non-obstructed. 4 patients reported one UTI episode with no cases of retention.RESULTS63 women were recruited and 48 finally included. At baseline, 20 reported 3 urinary tract infections (UTIs) during last year, and 12 had one episode of urine retention. Median Qmax was 7.5 ml/sec and median PVR 110 ml. 40 women were obstructed. 16 (40%) had mild, 16 (40%) moderate and 8 (20%) severe obstruction. All subjects had an overactive pelvic floor on EMG. Obstructed women were re-evaluated. Median Qmax was 8.5 ml/sec, close to baseline (p = 0.16). Median PVR was 65 ml, reduced to baseline (p = 0.02). 33 (82.5%) remained obstructed, 22 (66.67%) with mild, 8 (24.24%) moderate and 3 (9.09%) severe obstruction. 7 (17.5%) were non-obstructed. 4 patients reported one UTI episode with no cases of retention.A 6 month PFMT reduced UTIs and PVR in women with functional BOO. Additionally, most patients had a de-escalation to milder obstruction.CONCLUSIONSA 6 month PFMT reduced UTIs and PVR in women with functional BOO. Additionally, most patients had a de-escalation to milder obstruction. |
Author | Ioannis, Tsikopoulos Lazaros, Tzelves Christina, Papathanasiou Vasileios, Sakalis Michael, Samarinas |
Author_xml | – sequence: 1 givenname: Tzelves surname: Lazaros fullname: Lazaros, Tzelves organization: 2nd Department of Urology, Sismanoglio Hospital – sequence: 2 givenname: Tsikopoulos surname: Ioannis fullname: Ioannis, Tsikopoulos organization: Department of Urology, General Hospital of Larissa – sequence: 3 givenname: Sakalis surname: Vasileios fullname: Vasileios, Sakalis organization: Department of Urology, General Hospital of Thessaloniki ‘Agios Pavlos’ – sequence: 4 givenname: Papathanasiou surname: Christina fullname: Christina, Papathanasiou organization: Physiotherapy Center “Physiozw” – sequence: 5 givenname: Samarinas orcidid: 0000-0001-9424-795X surname: Michael fullname: Michael, Samarinas email: mikesamih@hotmail.com organization: Department of Urology, General Hospital of Larissa |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36695900$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UU1rVTEUDFKxH_oHXEjAjZurJ7kfyd0IUqwKBTd1a8jLPXkvJTd5JrkV--ub11dr7aIEksCZmTPMHJODEAMS8prBewYgPmSADroGeNvAMLbQXD8jR6xreQOCsYMH_0NynPMlAONSDi_IYTsMYz8CHJGfFxukaC2aQqOlW_RXzlDrY0x0XrLxSEvSLriwpi7Q33HGeruyoXYJprgYtKcrr6cJE41L8Vh1Vrmk5Xb4kjy32md8dfeekB9nny9Ovzbn3798O_103phOdKUxwva9acfJdNhxDa1FwaaVmKTkCMCFrIa5FoMdejl1I0dtepwEQqcFSNGekI973e2ymnEyGKprr7bJzTr9UVE79f8kuI1axys1StHXUwXe3Qmk-GvBXNTsskHvdcC4ZMXFLjHWj22Fvn0EvYxLqjlUlATOBADIinrz0NG9lb_RVwDfA0yKOSe09xAGatev2verar_qtl91XUnyEcm4ondJ71ryT1PbPTXXPWGN6Z_tJ1g3Pge7ug |
CitedBy_id | crossref_primary_10_7759_cureus_36730 crossref_primary_10_1002_nau_25241 crossref_primary_10_1055_a_2103_8631 |
Cites_doi | 10.1007/s00192-020-04588-8 10.1007/BF00182664 10.1097/MOU.0000000000000074 10.5213/inj.2040342.171 10.1016/S0031-9406(05)61108-X 10.1016/j.urology.2009.11.019 10.1016/S0022-5347(17)55287-8 10.1007/s11934-016-0586-2 10.1097/GCO.0000000000000584 10.1007/s11934-019-0901-9 10.1002/nau.20798 10.1093/ptj/pzx006 10.1002/nau.20107 10.1590/s1677-5538.ibju.2021.0687 10.1007/s00192-018-3599-1 10.1016/j.aju.2013.07.005 10.1046/j.1464-410X.1998.00866.x 10.1038/s41598-021-93283-9 10.1097/01.ju.0000176487.64283.36 10.1016/j.jogoh.2020.102032 10.1002/nau.10052 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. Copyright Springer Nature B.V. May 2023 The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. – notice: Copyright Springer Nature B.V. May 2023 – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1007/s00404-023-06930-z |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest One Academic Eastern Edition MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-0711 |
EndPage | 1494 |
ExternalDocumentID | PMC9875757 36695900 10_1007_s00404_023_06930_z |
Genre | Journal Article |
GroupedDBID | --- -Y2 .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 2.D 203 23N 28- 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 7X7 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AAJSJ AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABBBX ABBRH ABBXA ABDBE ABDZT ABECU ABEEZ ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABUWG ABWNU ABXPI ACBXY ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACUDM ACULB ACZOJ ADBBV ADHIR ADHKG ADIMF ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDZB AFEXP AFGXO AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHPBZ AHSBF AHYZX AIAKS AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD AYFIA AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI C6C CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PT4 PT5 QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 ZMTXR ZOVNA ZXP ~EX AAYXX ABFSG ACSTC AEZWR AFHIU AFOHR AHWEU AIXLP ATHPR CITATION CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c474t-c7f55c39dc4e42a03fe71db7d882e002786692a76f658d492eac5ed7e04a70873 |
IEDL.DBID | 7X7 |
ISSN | 1432-0711 0932-0067 |
IngestDate | Tue Sep 30 17:16:15 EDT 2025 Sun Sep 28 07:26:14 EDT 2025 Mon Jun 30 11:38:08 EDT 2025 Thu Apr 03 07:06:01 EDT 2025 Wed Oct 01 06:35:31 EDT 2025 Thu Apr 24 22:56:34 EDT 2025 Thu Apr 10 07:46:03 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Voiding dysfunction Pelvic floor muscle training Functional bladder outlet obstruction Female lower urinary tract symptoms |
Language | English |
License | 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c474t-c7f55c39dc4e42a03fe71db7d882e002786692a76f658d492eac5ed7e04a70873 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-9424-795X |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC9875757 |
PMID | 36695900 |
PQID | 2802170008 |
PQPubID | 4408561 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9875757 proquest_miscellaneous_2769591593 proquest_journals_2802170008 pubmed_primary_36695900 crossref_primary_10_1007_s00404_023_06930_z crossref_citationtrail_10_1007_s00404_023_06930_z springer_journals_10_1007_s00404_023_06930_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-05-01 |
PublicationDateYYYYMMDD | 2023-05-01 |
PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
PublicationTitle | Archives of gynecology and obstetrics |
PublicationTitleAbbrev | Arch Gynecol Obstet |
PublicationTitleAlternate | Arch Gynecol Obstet |
PublicationYear | 2023 |
Publisher | Springer Berlin Heidelberg Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
References | A Abdel Raheem (6930_CR7) 2013; 11 P Abrams (6930_CR2) 2002; 21 ET Massolt (6930_CR5) 2005; 24 KV Mytilekas (6930_CR6) 2021; 25 V Blanchard (6930_CR19) 2021; 50 J Laycock (6930_CR10) 2001; 87 HC Frawley (6930_CR20) 2017; 97 W Artibani (6930_CR16) 2014; 24 KRU da Mata (6930_CR24) 2021; 32 H Riaz (6930_CR17) 2022; 72 CS Lim (6930_CR4) 1995; 13 I Naess (6930_CR9) 2018; 29 WE Kaplan (6930_CR14) 1980; 124 SS Ladi-Seyedian (6930_CR22) 2019; 20 E Sam (6930_CR23) 2022; 48 6930_CR1 S Yagci (6930_CR12) 2005; 174 CH Chiang (6930_CR21) 2021; 11 BT Haylen (6930_CR3) 2010; 29 DS Hoffman (6930_CR8) 2016; 17 SL Wallace (6930_CR18) 2019; 31 FM Deindl (6930_CR15) 1998; 82 KH Pang (6930_CR11) 2021; S2405–4569 D Minardi (6930_CR13) 2010; 75 |
References_xml | – volume: 32 start-page: 249 issue: 2 year: 2021 ident: 6930_CR24 publication-title: Int Urogynecol J doi: 10.1007/s00192-020-04588-8 – volume: 13 start-page: 34 issue: 1 year: 1995 ident: 6930_CR4 publication-title: World J Urol doi: 10.1007/BF00182664 – volume: 24 start-page: 330 issue: 4 year: 2014 ident: 6930_CR16 publication-title: Curr Opin Urol doi: 10.1097/MOU.0000000000000074 – volume: 25 start-page: 244 issue: 3 year: 2021 ident: 6930_CR6 publication-title: Int Neurourol J doi: 10.5213/inj.2040342.171 – volume: 87 start-page: 631 issue: 12 year: 2001 ident: 6930_CR10 publication-title: Physiotherapy doi: 10.1016/S0031-9406(05)61108-X – volume: 75 start-page: 1299 issue: 6 year: 2010 ident: 6930_CR13 publication-title: Urology doi: 10.1016/j.urology.2009.11.019 – volume: 124 start-page: 48 issue: 1 year: 1980 ident: 6930_CR14 publication-title: J Urol doi: 10.1016/S0022-5347(17)55287-8 – volume: 17 start-page: 31 issue: 4 year: 2016 ident: 6930_CR8 publication-title: Curr Urol Rep doi: 10.1007/s11934-016-0586-2 – volume: 31 start-page: 485 issue: 6 year: 2019 ident: 6930_CR18 publication-title: Curr Opin Obstet Gynecol doi: 10.1097/GCO.0000000000000584 – volume: 20 start-page: 38 issue: 7 year: 2019 ident: 6930_CR22 publication-title: Curr Urol Rep doi: 10.1007/s11934-019-0901-9 – volume: 29 start-page: 4 year: 2010 ident: 6930_CR3 publication-title: Neurourol Urodyn doi: 10.1002/nau.20798 – volume: S2405–4569 start-page: 00231 issue: 21 year: 2021 ident: 6930_CR11 publication-title: Eur Urol Focus – volume: 97 start-page: 425 issue: 4 year: 2017 ident: 6930_CR20 publication-title: Phys Ther doi: 10.1093/ptj/pzx006 – volume: 24 start-page: 237 issue: 3 year: 2005 ident: 6930_CR5 publication-title: Neurourol Urodyn doi: 10.1002/nau.20107 – volume: 48 start-page: 501 issue: 3 year: 2022 ident: 6930_CR23 publication-title: Int Braz J Urol doi: 10.1590/s1677-5538.ibju.2021.0687 – volume: 29 start-page: 1623 issue: 11 year: 2018 ident: 6930_CR9 publication-title: Int Urogynecol J doi: 10.1007/s00192-018-3599-1 – volume: 72 start-page: 1456 issue: 7 year: 2022 ident: 6930_CR17 publication-title: J Pak Med Assoc – ident: 6930_CR1 – volume: 11 start-page: 319 issue: 4 year: 2013 ident: 6930_CR7 publication-title: Arab J Urol doi: 10.1016/j.aju.2013.07.005 – volume: 82 start-page: 814 issue: 6 year: 1998 ident: 6930_CR15 publication-title: Br J Urol doi: 10.1046/j.1464-410X.1998.00866.x – volume: 11 start-page: 13757 year: 2021 ident: 6930_CR21 publication-title: Sci Rep doi: 10.1038/s41598-021-93283-9 – volume: 174 start-page: 1994 issue: 5 year: 2005 ident: 6930_CR12 publication-title: J Urol doi: 10.1097/01.ju.0000176487.64283.36 – volume: 50 issue: 4 year: 2021 ident: 6930_CR19 publication-title: J Gynecol Obstet Hum Reprod doi: 10.1016/j.jogoh.2020.102032 – volume: 21 start-page: 167 year: 2002 ident: 6930_CR2 publication-title: Neurourol Urodyn doi: 10.1002/nau.10052 |
SSID | ssj0012886 |
Score | 2.3445702 |
Snippet | Introduction and hypothesis
Female voiding dysfunction is often due to bladder outlet obstruction (BOO). We investigated pelvic floor muscle training (PFMT)... Female voiding dysfunction is often due to bladder outlet obstruction (BOO). We investigated pelvic floor muscle training (PFMT) effectiveness in women with... Introduction and hypothesisFemale voiding dysfunction is often due to bladder outlet obstruction (BOO). We investigated pelvic floor muscle training (PFMT)... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1489 |
SubjectTerms | Electromyography Endocrinology Female General Gynecology Gynecology Human Genetics Humans Medicine Medicine & Public Health Nomograms Obstetrics/Perinatology/Midwifery Pelvic Floor Pelvis Prospective Studies Urinary Bladder Neck Obstruction - diagnosis Urinary Bladder Neck Obstruction - therapy Urinary Retention Urinary tract infections Urination - physiology Urodynamics - physiology Urogenital system |
SummonAdditionalLinks | – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1JS8UwEB5cQLyIu3Ujgjct9DVbc5SH8hCeJwVPlqRNUXi24nLx1zuT9lWeG3jOTJeZJPMlM_kCcOy0tZVOFS5yaLfKiSI23OvYGpVhAHOZLemA8_hKjW7E5a287Why6CzMl_x9IPukOomU7iAwPInf52FR4sRL5XtDNewzBmmWqe5QzM96s4HnG5r8XhT5JTMaAs7FKqx0SJGdta5dgzlfr8PSuMuFb8Adepi15RisqdiTn-CgZ9WkaZ7Z49sL6rDp_Q_soWaBaoHRtiujWNZuATI3oZnnmYW6IHyO6_lkN-Hm4vx6OIq72xLiQmjxGhe6krLgpiyEF6lNeOX1oHS6RAztQ4JRKZNarSoEHaUwKU650pfaJ8LqJNN8CxbqpvY7wJyvDAIjhYpWCJ65xGhZlIhlKsUHhYxgMDVlXnRU4vRHk7wnQQ7mz9H8eTB__h7BSa_z1BJp_Cm9P_VQ3g2qlzzNaAFFqCWCo74ZhwPlOGztmzeU0cpIgxiNR7DdOrR_HVfUliQR6BlX9wJEtT3bUj_cB8ptQ7z_UkdwOu0Un5_1-1_s_k98D5bT0GGpnHIfFtDh_gAhz6s7DH39Az-H-lw priority: 102 providerName: Springer Nature |
Title | The effect of pelvic floor muscle training in women with functional bladder outlet obstruction |
URI | https://link.springer.com/article/10.1007/s00404-023-06930-z https://www.ncbi.nlm.nih.gov/pubmed/36695900 https://www.proquest.com/docview/2802170008 https://www.proquest.com/docview/2769591593 https://pubmed.ncbi.nlm.nih.gov/PMC9875757 |
Volume | 307 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1432-0711 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0012886 issn: 1432-0711 databaseCode: AFBBN dateStart: 19970101 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1432-0711 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0012886 issn: 1432-0711 databaseCode: 7X7 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Proquest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1432-0711 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0012886 issn: 1432-0711 databaseCode: BENPR dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVAVX databaseName: Springer Nature HAS Fully OA customDbUrl: eissn: 1432-0711 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0012886 issn: 1432-0711 databaseCode: AAJSJ dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature Open Access Journals customDbUrl: eissn: 1432-0711 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0012886 issn: 1432-0711 databaseCode: C6C dateStart: 18700201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1432-0711 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0012886 issn: 1432-0711 databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1432-0711 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0012886 issn: 1432-0711 databaseCode: U2A dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_BJiFeEN9kjMlIvIFFmjh2_IRK1TGBNiFEpfJCZDuONqkkZd1e9tfvznEylYm9tFJtN7HvfPfz3fkO4J1VxjQqk3jIIWuVFY7r3CtutCxRgdnS1HTB-fhEHi3E12WxjAa3TQyrHGRiENR158hG_jErCT2Tyvq0_supahR5V2MJjfuwO0GoQlytluOBC0VvqPSIh_aMk1iOl2bC1TniXsFRY_GUqgHyq23FdAtt3g6a_MdzGhTS4WN4FJEkm_akfwL3fPsUHhxHX_kz-I0cwPpwDdY1bO1XKBRYs-q6c_bncoNj2FAfgp21LKRiYGSWZaTrehMhsyuSTOcsxA3h_9gx3-xzWBzOf86OeKymwJ1Q4oI71RSFy3XthBeZSfPGq0ltVY0Y2wcHpJQ6M0o2CEpqoTMUyYWvlU-FUWmp8hew03atfwXM-kYjcJI40AiRlzbVqnA1Yp1G5hNXJDAZlrJyMdU4zWhVjUmSw_JXuPxVWP7qKoH345h1n2jjzt77A4WquOk21Q2LJPB2bMbtQj4Q0_ruEvsoqQuNGC5P4GVP0PFxuaS2NE1AbZF67ECpuLdb2rPTkJJbU12AQiXwYWCKm9f6_yz27p7Fa3iYBQal8Mp92EEC-zcIgS7sQeDzA9idfvn1bY7fn-cn33_grzM5w89FNr0GQBcH3g |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxJvQAkaCE1jNJo4dHyqEgGpLuz210p4ItuOISttk222F6I_qb-yM86iWit569iPxzHjms2c8A_DeKmMqlUg85NBtlRWO69QrbrTM0YDZ3JT0wHmyJ8cH4sc0m67ARf8WhsIqe50YFHXZOLoj30hyQs9ksj7PjzlVjSLval9CoxWLHf_3Dx7ZFpvb35C_H5Jk6_v-1zHvqgpwJ5Q45U5VWeZSXTrhRWLitPJqVFpVItb0wREnpU6MkhUa51LoBFVT5kvlY2FUnKsU570Dd0UaC8rVr6bDAQ9VfagsGSMm4mQGukc64ake7RbB0ULymKoP8vNlQ3gN3V4P0vzHUxsM4NYjeNghV_alFbXHsOLrJ3Bv0vnmn8JPlDjWhoewpmJzP0MlxKpZ05ywo7MFjmF9PQp2WLOQ-oHRNTAj29peSTI7I014wkKcEs5jh_y2z-DgVuj8HFbrpvYvgVlfaQRqEgcaIdLcxlplrkRsVcl05LIIRj0pC9elNqcVzYohKXMgf4HkLwL5i_MIPg5j5m1ijxt7r_ccKrpNviiuRDKCd0Mzbk_yuZjaN2fYR0mdacSMaQQvWoYOn0sltcVxBGqJ1UMHSv293FIf_g4pwDXVIchUBJ96obj6rf-v4tXNq3gL98f7k91id3tvZw0eJEFYKbRzHVaR2f41wq9T-ybIPINft73JLgEjAz9k |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZT9wwEB5RkFBfENAC4XQl3tqIbOIjflwBK1gOIVEknhrZiS1WWpIVLC_8esbO0S5QJJ49zjEz9nz2XAD7WihlRczxkONuqzTNQ5kYESrJUzRgOlWFS3C-uOQnN3R4y27_yeL30e6tS7LOaXBVmsrpwaSwB13im9M9GqK9CSPXyy98_gILKZMcj18L_f7weth5EuI05U2yzPszZw3SG5T5NljylcfUG6LBMiw1CJL0a5GvwJwpV2HxovGRf4M_KHlSh2mQypKJGeNmQOy4qh7I_dMjziFtXwgyKokvwUDcdSxxNq6-GiR67HakB-LjhfA5uqsz-x1uBse_D0_CpotCmFNBp2EuLGN5IoucGhqrKLFG9AotCsTWxjseOZexEtwiGCmojHErZqYQJqJKRKlI1mC-rEqzAUQbKxEwcZyoKE1SHUnB8gIxjuVJL2cB9FpWZnlTYtz90TjriiN79mfI_syzP3sO4Gc3Z1IX2PiQeruVUNYstscsTt3ByqGZAH50w7hMnO9DlaZ6QhrBJZOI3ZIA1muBdq9LuBuLogDEjKg7AleCe3akHN35UtzS9QNgIoBfrVL8_az__8Xm58j3YPHqaJCdn16ebcHX2Ouui7jchnmUvdlBVDTVu43ivwDClwcW |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+pelvic+floor+muscle+training+in+women+with+functional+bladder+outlet+obstruction&rft.jtitle=Archives+of+gynecology+and+obstetrics&rft.date=2023-05-01&rft.pub=Springer+Nature+B.V&rft.issn=0932-0067&rft.eissn=1432-0711&rft.volume=307&rft.issue=5&rft.spage=1489&rft.epage=1494&rft_id=info:doi/10.1007%2Fs00404-023-06930-z |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1432-0711&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1432-0711&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1432-0711&client=summon |